PRODUCTS SOLD ON POWERPEPTIDES.CO.UK ARE FOR RESEARCH PURPOSES ONLY AND ARE NOT FOR HUMAN OR VETERINARY USE.

FOX04

⚠️ PRODUCTS SOLD ON POWERPEPTIDES.CO.UK ARE FOR RESEARCH PURPOSES ONLY AND ARE NOT FOR HUMAN OR VETERINARY USE.

FOXO4-DRI is a synthetic research peptide studied for its interaction with the FOXO transcription factor pathway and its role in cellular senescence modelling. Supplied in a 10 mg lyophilised vial with ≥98% purity (HPLC certified), intended strictly for laboratory-based research use.

  • 10 mg lyophilised research peptide
  • FOXO transcription factor pathway analogue
  • ≥98% purity (HPLC verified)

For laboratory research use only. Not for human or veterinary use.

£150.00

SKU: PP-FOXO4-10
Brand: Power Peptides

⚠️ For laboratory research use only. Not for human or veterinary use.

View Certificate of Analysis (COA)
  • High-purity research-grade formulation
  • Independently analysed via HPLC & LC-MS
  • Batch-specific COA available
  • UK-based dispatch & tracking
🔬 HPLC Verified 📦 Batch Traceable 🚚 UK Dispatch 🔒 Secure Checkout
⚠️ IMPORTANT RESEARCH NOTICE
All products supplied by Power Peptides are research-grade reagents. Not for human consumption, medical, veterinary, or diagnostic use.

What is FOXO4-DRI?

FOXO4-DRI is a synthetic research peptide designed to study biochemical pathways related to cellular senescence, transcription factor regulation, and apoptosis modelling. This peptide specifically interacts with the FOXO4 transcription factor, making it of interest in ageing-related research and cell survival studies conducted in vitro. FOXO4-DRI is supplied in lyophilised form and verified at ≥98% purity for high-precision laboratory applications.

Research Applications

  • Investigation of FOXO transcription factor pathways
  • Cellular senescence modelling
  • Biochemical peptide–protein interaction studies
  • In vitro apoptosis and survival signalling research

Key Features

  • 10 mg lyophilised peptide vial
  • Designed for senescence pathway research
  • ≥98% purity (HPLC verified)
  • Batch-specific Certificate of Analysis available

Specifications

Compound Name FOXO4-DRI
Form Lyophilised peptide powder
Amount Available 10 mg
Purity ≥98% (HPLC verified)
Peptide Type Transcription factor peptide analogue
Appearance White to off-white lyophilised powder
Solubility Soluble in bacteriostatic water or appropriate solvent
Storage (unopened) –20 °C, protected from light
Storage (after reconstitution) 2–8 °C; aliquoting recommended to maintain stability
Documentation Certificate of Analysis (COA) available upon request

Reconstitution & Handling

  • Reconstitute using sterile bacteriostatic water or compatible solvent
  • Gently swirl until dissolved
  • Use aseptic techniques

Quality & Testing

FOXO4-DRI from Power Peptides is independently tested via high-performance liquid chromatography (HPLC) and mass spectrometry to confirm molecular identity and ≥98% purity. Each batch is fully traceable and accompanied by analytical documentation.

Important Notice

For laboratory research use only. This compound is not intended for human use, medical treatment, or veterinary application.

FOX04
£150.00